Human T cell reconstitution in DiGeorge syndrome and HIV-1 infection

Seminars in Immunology

Volumn 19, Issue 5, 2007, Pages 297-309

  Hudson, Lori L ^a,b   Louise Markert, M ^a,b   Devlin, Blythe H ^a,b   Haynes, Barton F ^a,b   Sempowski, Gregory D ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anti retroviral drugs; DiGeorge syndrome; HIV AIDS; Thymopoiesis; Thymus

Indexed keywords

ANTIRETROVIRUS AGENT; FLUORODEOXYGLUCOSE F 18; GROWTH HORMONE; INTERLEUKIN 2; INTERLEUKIN 7; KERATINOCYTE GROWTH FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN RECOGNITION; CD4+ T LYMPHOCYTE; CELL MATURATION; CHILD CARE; COMPUTER ASSISTED TOMOGRAPHY; DIGEORGE SYNDROME; DISEASE COURSE; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; REVIEW; T LYMPHOCYTE ACTIVATION; THYMUS TRANSPLANTATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; DIGEORGE SYNDROME; HIV-1; HUMANS; INTERLEUKIN-2; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; THYMUS GLAND;

EID: 36549062871     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2007.10.002     Document Type: Review

References (112)

1. Haynes B.F., Markert M.L., Sempowski G.D., Patel D.D., and Hale L.P. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol 18 (2000) 529-560
2. Haynes B.F., Sempowski G.D., Wells A.F., and Hale L.P. The human thymus during aging. Immunol Res 22 (2000) 253-261
3. Parham P. The Immune System (2000), Garland Publishing/Elsevier Science Ltd., New York, NY
4. Miosge L., and Zamoyska R. Signalling in T-cell development: is it all location, location, location?. Curr Opin Immunol 19 (2007) 194-199
5. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 6 (2006) 127-135
6. van den Brink M.R., Alpdogan O., and Boyd R.L. Strategies to enhance T-cell reconstitution in immunocompromised patients. Nat Rev Immunol 4 (2004) 856-867
7. Douek D.C., McFarland R.D., Keiser P.H., Gage E.A., Massey J.M., Haynes B.F., et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 396 (1998) 690-695
8. McCune J.M., Loftus R., Schmidt D.K., Carroll P., Webster D., Swor-Yim L.B., et al. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest 101 (1998) 2301-2308
9. Patel P., Alibazoglu H., Ali A., Fordham E., and LaMonica G. Normal thymic uptake of FDG on PET imaging. Clin Nucl Med 21 (1996) 772-775
10. Nakahara T., Fujii H., Ide M., Nishiumi N., Takahashi W., Yasuda S., et al. FDG uptake in the morphologically normal thymus: comparison of FDG positron emission tomography and CT. Br J Radiol 74 (2001) 821-824
11. Ferdinand B., Gupta P., and Kramer E.L. Spectrum of thymic uptake at 18F-FDG PET. Radiographics 24 (2004) 1611-1616
12. De Rosa S.C., Herzenberg L.A., Herzenberg L.A., and Roederer M. 11-Color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med 7 (2001) 245-248
13. McFarland R.D., Douek D.C., Koup R.A., and Picker L.J. Identification of a human recent thymic emigrant phenotype. Proc Natl Acad Sci USA 97 (2000) 4215-4220
14. Mackall C.L., Granger L., Sheard M.A., Cepeda R., and Gress R.E. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 82 (1993) 2585-2594
15. Kong F., Chen C.H., and Cooper M.D. Thymic function can be accurately monitored by the level of recent T cell emigrants in the circulation. Immunity 8 (1998) 97-104
16. Picker L.J., Treer J.R., Ferguson-Darnell B., Collins P.A., Buck D., and Terstappen L.W. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor l-selectin on T cells during the virgin to memory cell transition. J Immunol 150 (1993) 1105-1121
17. Haynes B.F., Hale L.P., Weinhold K.J., Patel D.D., Liao H.X., Bressler P.B., et al. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest 103 (1999) 453-460
18. Steffens C.M., Al-Harthi L., Shott S., Yogev R., and Landay A. Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naive phenotypes. Clin Immunol 97 (2000) 95-101
19. Sallusto F., Geginat J., and Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22 (2004) 745-763
20. Kern F., LiPira G., Gratama J.W., Manca F., and Roederer M. Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer. Trends Immunol 26 (2005) 477-484
21. Casazza J.P., Betts M.R., Price D.A., Precopio M.L., Ruff L.E., Brenchley J.M., et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med 203 (2006) 2865-2877
22. Kovacs J.A., Lempicki R.A., Sidorov I.A., Adelsberger J.W., Sereti I., Sachau W., et al. Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J Clin Invest 115 (2005) 2139-2148
23. Douek D. Thymic output and HIV infection: on the right TREC. Immunity 21 (2004) 744-745
24. Hazenberg M.D., Borghans J.A., de Boer R.J., and Miedema F. Thymic output: a bad TREC record. Nat Immunol 4 (2003) 97-99
25. Hazenberg M.D., Verschuren M.C., Hamann D., Miedema F., and van Dongen J.J. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med 79 (2001) 631-640
26. Ye P., and Kirschner D.E. Measuring emigration of human thymocytes by T-cell receptor excision circles. Crit Rev Immunol 22 (2002) 483-497
27. Ye P., and Kirschner D.E. Reevaluation of T cell receptor excision circles as a measure of human recent thymic emigrants. J Immunol 168 (2002) 4968-4979
28. Dion M.L., Poulin J.F., Bordi R., Sylvestre M., Corsini R., Kettaf N., et al. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 21 (2004) 757-768
29. Almeida A.R., Borghans J.A., and Freitas A.A. T cell homeostasis: thymus regeneration and peripheral T cell restoration in mice with a reduced fraction of competent precursors. J Exp Med 194 (2001) 591-599
30. Dion M.L., Bordi R., Zeidan J., Asaad R., Boulassel M.R., Routy J.P., et al. Slow disease progression and robust therapy-mediated CD4+ T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection. Blood 109 (2006) 2912-2920
31. Douek D.C., Picker L.J., and Koup R.A. T cell dynamics in HIV-1 infection. Annu Rev Immunol 21 (2003) 265-304
32. Davis M.M., and Bjorkman P.J. T-cell antigen receptor genes and T-cell recognition. Nature 334 (1988) 395-402
33. Rosenberg W.M., Moss P.A., and Bell J.I. Variation in human T cell receptor V beta and J beta repertoire: analysis using anchor polymerase chain reaction. Eur J Immunol 22 (1992) 541-549
34. Ria F., van den Elzen P., Madakamutil L.T., Miller J.E., Maverakis E., and Sercarz E.E. Molecular characterization of the T cell repertoire using immunoscope analysis and its possible implementation in clinical practice. Curr Mol Med 1 (2001) 297-304
35. Pannetier C., Cochet M., Darche S., Casrouge A., Zoller M., and Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 90 (1993) 4319-4323
36. Han M., Harrison L., Kehn P., Stevenson K., Currier J., and Robinson M.A. Invariant or highly conserved TCR alpha are expressed on double-negative (CD3+CD4-CD8-) and CD8+ T cells. J Immunol 163 (1999) 301-311
37. Pannetier C., Even J., and Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 16 (1995) 176-181
38. Garcia A.M., Fadel S.A., Cao S., and Sarzotti M. T cell immunity in neonates. Immunol Res 22 (2000) 177-190
39. Kepler T.B., He M., Tomfohr J.K., Devlin B.H., Sarzotti M., and Markert M.L. Statistical analysis of antigen receptor spectratype data. Bioinformatics 21 (2005) 3394-3400
40. He M., Tomfohr J.K., Devlin B.H., Sarzotti M., Markert M.L., and Kepler T.B. SpA: web-accessible spectratype analysis: data management, statistical analysis and visualization. Bioinformatics 21 (2005) 3697-3699
41. Conley M.E., Beckwith J.B., Mancer J.F., and Tenckhoff L. The spectrum of the DiGeorge syndrome. J Pediatr 94 (1979) 883-890
42. Barrett D.J., Ammann A.J., Wara D.W., Cowan M.J., Fisher T.J., and Stiehm E.R. Clinical and immunologic spectrum of the DiGeorge syndrome. J Clin Lab Immunol 6 (1981) 1-6
43. Thomas R.A., Landing B.H., and Wells T.R. Embryologic and other developmental considerations of 38 possible variants of the DiGeorge anomaly. Am J Med Genet Suppl 3 (1987) 43-66
44. Muller W., Peter H.H., Wilken M., Juppner H., Kallfelz H.C., Krohn H.P., et al. The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr 147 (1988) 496-502
45. Ryan A.K., Goodship J.A., Wilson D.I., Philip N., Levy A., Seidel H., et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34 (1997) 798-804
46. Markert M.L., Devlin B.H., Alexieff M.J., Li J., McCarthy E.A., Gupton S.E., et al. Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood 109 (2007) 4539-4547
47. Markert M.L., Alexieff M.J., Li J., Sarzotti M., Ozaki D.A., Devlin B.H., et al. Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in five cases. J Allerg Clin Immunol 113 (2004) 734-741
48. Markert M.L., Hummell D.S., Rosenblatt H.M., Schiff S.E., Harville T.O., Williams L.W., et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr 132 (1998) 15-21
49. Hong R. Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy. Clin Immunol Immunopathol 40 (1986) 136-141
50. Markert M.L., Alexieff M.J., Li J., Sarzotti M., Ozaki D.A., Devlin B.H., et al. Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood 104 (2004) 2574-2581
51. Markert M.L., Boeck A., Hale L.P., Kloster A.L., McLaughlin T.M., Batchvarova M.N., et al. Transplantation of thymus tissue in complete DiGeorge syndrome [see comment]. N Engl J Med 341 (1999) 1180-1189
52. Markert M.L., Sarzotti M., Ozaki D.A., Sempowski G.D., Rhein M.E., Hale L.P., et al. Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood 102 (2003) 1121-1130
53. Markert M.L., Kostyu D.D., Ward F.E., McLaughlin T.M., Watson T.J., Buckley R.H., et al. Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymus. J Immunol 158 (1997) 998-1005
54. von Boehmer H., Aifantis I., Gounari F., Azogui O., Haughn L., Apostolou I., et al. Thymic selection revisited: how essential is it?. Immunol Rev 191 (2003) 62-78
55. Choi E.Y., Jung K.C., Park H.J., Chung D.H., Song J.S., Yang S.D., et al. Thymocyte-thymocyte interaction for efficient positive selection and maturation of CD4 T cells. Immunity 23 (2005) 387-396
56. Li W., Kim M.G., Gourley T.S., McCarthy B.P., Sant'Angelo D.B., and Chang C.H. An alternate pathway for CD4 T cell development: thymocyte-expressed MHC class II selects a distinct T cell population. Immunity 23 (2005) 375-386
57. Sleasman J.W., and Goodenow M.M. 13. HIV-1 infection. J Allerg Clin Immunol 111 (2003) S582-S592
58. Hay C., and Rosenberg E. Immunologic response to HIV. AIDS Clin Care 10 (1998) 1-3
59. Rosenberg Y.J., Anderson A.O., and Pabst R. HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking?. Immunol Today 19 (1998) 10-17
60. Rosenberg E.S., and Walker B.D. HIV type 1-specific helper T cells: a critical host defense. AIDS Res Hum Retroviruses 14 Suppl 2 (1998) S143-S147
61. Walker R.E., Carter C.S., Muul L., Natarajan V., Herpin B.R., Leitman S.F., et al. Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults. Nat Med 4 (1998) 852-856
62. Walker B.D., Rosenberg E.S., Hay C.M., Basgoz N., and Yang O.O. Immune control of HIV-1 replication. Adv Exp Med Biol 452 (1998) 159-167
63. Rosenberg E.S., Billingsley J.M., Caliendo A.M., Boswell S.L., Sax P.E., Kalams S.A., et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278 (1997) 1447-1450
64. Kaul R., Rowland-Jones S.L., Kimani J., Fowke K., Dong T., Kiama P., et al. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 79 (2001) 3-13
65. Fowke K.R., Kaul R., Rosenthal K.L., Oyugi J., Kimani J., Rutherford W.J., et al. HIV-1-specific cellular immune responses among HIV-1-resistant sex workers. Immunol Cell Biol 78 (2000) 586-595
66. Alimonti J.B., Ball T.B., and Fowke K.R. Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol 84 (2003) 1649-1661
67. Finkel T.H., Tudor-Williams G., Banda N.K., Cotton M.F., Curiel T., Monks C., et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1 (1995) 129-134
68. McCune J.M. Thymic function in HIV-1 disease. Semin Immunol 9 (1997) 397-404
69. Teixeira L., Valdez H., McCune J.M., Koup R.A., Badley A.D., Hellerstein M.K., et al. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 15 (2001) 1749-1756
70. Markert M.L., Alvarez-McLeod A.P., Sempowski G.D., Hale L.P., Horvatinovich J.M., Weinhold K.J., et al. Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy. AIDS Res Hum Retroviruses 17 (2001) 1635-1643
71. Douek D.C., Betts M.R., Hill B.J., Little S.J., Lempicki R., Metcalf J.A., et al. Evidence for increased T cell turnover and decreased thymic output in HIV infection. J Immunol 167 (2001) 6663-6668
72. Haynes B.F. HIV infection and the dynamic interplay between the thymus and the peripheral T cell pool. Clin Immunol 92 (1999) 3-5
73. Sempowski G.D., Hicks C.B., Eron J.J., Bartlett J.A., Hale L.P., Ferrari G., et al. Naive T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function. J Clin Immunol 25 (2005) 462-472
74. Mattapallil J.J., Douek D.C., Hill B., Nishimura Y., Martin M., and Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 (2005) 1093-1097
75. Veasey J.S., Metcalfe N.B., and Houston D.C. A reassessment of the effect of body mass upon flight speed and predation risk in birds. Anim Behav 56 (1998) 883-889
76. Guadalupe M., Reay E., Sankaran S., Prindiville T., Flamm J., McNeil A., et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77 (2003) 11708-11717
77. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200 (2004) 749-759
78. Mehandru S., Poles M.A., Tenner-Racz K., Horowitz A., Hurley A., Hogan C., et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200 (2004) 761-770
79. Shevach E.M. Certified professionals: CD4(+)CD25(+) suppressor T cells. J Exp Med 193 (2001) F41-F46
80. Suvas S., Kumaraguru U., Pack C.D., Lee S., Rouse B.T., and CD4+CD25+. T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 198 (2003) 889-901
81. Aandahl E.M., Michaelsson J., Moretto W.J., Hecht F.M., and Nixon D.F. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 78 (2004) 2454-2459
82. Kinter A.L., Hennessey M., Bell A., Kern S., Lin Y., Daucher M., et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status [see comment]. J Exp Med 200 (2004) 331-343
83. Autran B., Carcelain G., Li T.S., Blanc C., Mathez D., Tubiana R., et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277 (1997) 112-116
84. Connors M., Kovacs J.A., Krevat S., Gea-Banacloche J.C., Sneller M.C., Flanigan M., et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 3 (1997) 533-540
85. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., and Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 (1995) 123-126
86. Lange C.G., and Lederman M.M. Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection. J Antimicrob Chemother 51 (2003) 1-4
87. Wolthers K.C., Schuitemaker H., and Miedema F. Rapid CD4+ T-cell turnover in HIV-1 infection: a paradigm revisited. Immunol Today 19 (1998) 44-48
88. Zhang L., Lewin S.R., Markowitz M., Lin H.H., Skulsky E., Karanicolas R., et al. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med 190 (1999) 725-732
89. Hazenberg M.D., Otto S.A., Cohen Stuart J.W., Verschuren M.C., Borleffs J.C., Boucher C.A., et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 6 (2000) 1036-1042
90. Hardy G., Worrell S., Hayes P., Barnett C.M., Glass D., Pido-Lopez J., et al. Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection. HIV Med 5 (2004) 67-73
91. Wong J.K., Gunthard H.F., Havlir D.V., Zhang Z.Q., Haase A.T., Ignacio C.C., et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci USA 94 (1997) 12574-12579
92. Hunt P.W., Deeks S.G., Rodriguez B., Valdez H., Shade S.B., Abrams D.I., et al. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS 17 (2003) 1907-1915
93. Egger M., May M., Chene G., Phillips A.N., Ledergerber B., Dabis F., et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360 (2002) 119-129
94. Clerici M., Saresella M., Trabattoni D., Ferrante P., Vanzulli A., and Vigano A. Thymic volume predicts long-term immune reconstitution in HIV-infected children treated with highly active antiretroviral therapy. AIDS 16 (2002) 2219-2221
95. Kolte L., Dreves A.M., Ersboll A.K., Strandberg C., Jeppesen D.L., Nielsen J.O., et al. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J Infect Dis 185 (2002) 1578-1585
96. Vigano A., Vella S., Saresella M., Vanzulli A., Bricalli D., Di Fabio S., et al. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS 14 (2000) 251-261
97. Manfredi R., and Chiodo F. A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS 14 (2000) 1475-1477
98. Bidwell Goetz M., Morreale A.P., Rhew D.C., Berman S., Ing M., Eldridge D., et al. Effect of highly active antiretroviral therapy on outcomes in Veterans Affairs Medical Centers. AIDS 15 (2001) 530-532
99. Gruver A.L., Hudson L.L., and Sempowski G.D. Immunosenescence of ageing. J Pathol 211 (2007) 144-156
100. Pakker N.G., Notermans D.W., de Boer R.J., Roos M.T., de Wolf F., Hill A., et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 4 (1998) 208-214
101. Wolthers K.C., Bea G., Wisman A., Otto S.A., de Roda Husman A.M., Schaft N., et al. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 274 (1996) 1543-1547
102. Bucy R.P., Hockett R.D., Derdeyn C.A., Saag M.S., Squires K., Sillers M., et al. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Investig 103 (1999) 1391-1398
103. Savino W., Postel-Vinay M.C., Smaniotto S., and Dardenne M. The thymus gland: a target organ for growth hormone. Scand J Immunol 55 (2002) 442-452
104. Vigano A., Saresella M., Trabattoni D., Giacomet V., di Natale B., Merlo M., et al. Growth hormone in T-lymphocyte thymic and postthymic development: a study in HIV-infected children. J Pediatr 145 (2004) 542-548
105. Napolitano L.A., Lo J.C., Gotway M.B., Mulligan K., Barbour J.D., Schmidt D., et al. Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS 16 (2002) 1103-1111
106. Levy Y., Durier C., Krzysiek R., Rabian C., Capitant C., Lascaux A.S., et al. Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial. AIDS 17 (2003) 343-351
107. Valdez H., Mitsuyasu R., Landay A., Sevin A.D., Chan E.S., Spritzler J., et al. Interleukin-2 increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s. J Infect Dis 187 (2003) 320-325
108. Pido-Lopez J., Burton C., Hardy G., Pires A., Sullivan A., Gazzard B., et al. Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune). AIDS Res Hum Retroviruses 19 (2003) 103-109
109. Starr S.E., McFarland E.J., Muresan P., Fenton T., Pitt J., Douglas S.D., et al. Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected children. AIDS 17 (2003) 2181-2189
110. Shearer W.T., Rosenblatt H.M., Gelman R.S., Oyomopito R., Plaeger S., Stiehm E.R., et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the pediatric AIDS clinical trials group P1009 study. J Allerg Clin Immunol 112 (2003) 973-980
111. Hellerstein M., Hanley M.B., Cesar D., Siler S., Papageorgopoulos C., Wieder E., et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 5 (1999) 83-89
112. Macallan D.C., Fullerton C.A., Neese R.A., Haddock K., Park S.S., and Hellerstein M.K. Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans. Proc Natl Acad Sci USA 95 (1998) 708-713